RANBAXY OPENS THIRD R&D FACILITY IN GURGAON
Ranbaxy Laboratories Limited (Q, N,C,F)* (RLL) has opened its third state-of-the-art drug discovery research center at Gurgaon, India. The new R&D center will focus on New Drug Discovery and the Development Functions of Medicinal Chemistry, Analytical Development (NDDR), Pharmacology, Molecular Technologies, Infectious Diseases, Metabolism and Pharmacokinetics. Ranbaxy has the largest R&D budget in India amongst pharmaceutical companies. R&D productivity gains have been high and its strong research and innovation capabilities have led to the delivery of a robust product pipeline.